Interested in MediPaper's tailored and professional healthcare writer solutions? Our unique business model allows for sharp pricing! See how our medical writer agency can help your project and request a price estimation.
We appreciate your interest in working with MediPaper Medical Communications.
Hire Healthcare Writers
Want to stay up to date? Sign up for our newsletter
As CMS moves ahead with payment reforms designed to reduce the total cost of hospital care, the results from a new study show that cancer treatment remains much less expensive at community oncology clinics than at hospitals and that the spending gap between the 2 types of sites may be growing wider.
The European Commission has approved niraparib as a maintenance therapy for women with platinum-sensitive relapsed high-grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in complete or partial response to platinum-based chemotherapy.
A second course of radium-223 was associated with minimal hematologic toxicity and low radiographic bone progression rates in a phase I/II study of men with metastatic castration-resistant prostate cancer.